Nanna Luneborg
General Partner at Forbion
Nanna Luneborg
General Partner at Forbion
Amsterdam, North Holland
Overview
Work Experience
General Partner
2021 - Current
- General Partner, Forbion Growth Opportunities Fund - Late stage and crossover investments in biotech - Board director of Capstan, BioInvent, F2G, Noema and Inversago (acquired by Novo Nordisk), observer in Numab
Partner
2018 - 2021
• Partner in Novo Ventures • Board director in Numab, Lava (LVTX), ReViral (acquired by Pfizer), NodThera and Stargazer • Previous deals as lead investor/board director include NBE Therapeutics (acquired by Boehringer Ingelheim), Inventiva (IVA), Orphazyme (ORPHA), ObsEva (OBSV) and IO Biotech (IOBT)
Principal
2016 - 2017
• Principal in Novo Ventures
Investment Director
2013 - 2015
• Investment Director in Novo Seeds • Board member in IO Biotech, Inthera, Glionova, Affinicon, MinervaX, Pcovery, board observer in Galecto, ForEndo
Principal
2012 - 2013
• Principal in Novo Seeds • Seed stage biotech venture investment in Northern Europe
Associate
2008 - 2012
• Investment professional in a healthcare venture fund • Successful exits from both primary and secondary deals, incl Convergence, Ulthera, SureCalm • Multiple deals completed from initial diligence to closing • Various deal structures: primary/secondary investments, spin-out, start-up, management buy-in
Intern
2008 - 2008
MBA summer internship
Consulting project
2008 - 2008
MBA team consulting project: IP technology in UK healthcare
Consulting project
2007 - 2007
MBA team consulting project on business model and strategy for a biotech start-up
Senior Business Intelligence Analyst
2006 - 2007
• Business Intelligence on performance metrics across £315 M research portfolio • Strategic evaluation to CEO
Research Manager
2005 - 2006
• Financial and scientific analyses of research portfolio across organisation • Liaison with principal investigators and research organisations in UK and US
Graduate Research Associate
2000 - 2004
Research project leading to PhD thesis in development neuroscience
Marketing Manager
1996 - 1997
Managed marketing campaigns for international business conference and training group
Education
Master of Business Administration (MBA)
2007 - 2008
PhD
2000 - 2005
BA (1st class)
1997 - 2000
Certificate in Company Direction
2013 - 2013
Certificate in Investment Management
2009 - 2009